Abstract
At present, there exists no safe, convenient animal model for disseminated cryptococcosis to simulate the infection in patients with AIDS. We therefore developed an inhalation model of cryptococcosis using heterozygous HIV transgenic mice (Tg26). Those transgenic animals bear a subgenomic HIV-1 clone (pNL4-3 strain), containing a 3 kb deletion that spans the gag and pol genes and renders the provirus non-replicating and non-infectious. CD4+ T-cell numbers in peripheral blood are reduced. Tg 26 mice and imrmmologically intact littermates (FVB/N) were inoculated intranasally with 8×104 or 2×106 blastoconidia of a clinical strain of Cryptococcus neofomans, serotype A (A 49). Animals that received 8×104 organisms were sacrificed at week 5 for quantitative cultures and histopathologic examination; those receiving 2×106 organisms were examined following Cryptococcus-indüceä death between days 5 and 20. Essential findings were as follows: 1) 8×104 inoculum: Organism burdens were significantly greater in HIV transgenic animals than in normal littermates. 2) 2×106 inoculum: A) HIV transgenic animals exhibited a macrophage phagocytic defect, and B) animals that survived 2 to 3 weeks into the infection developed almost complete absence of pulmonary and central nervous system inflammation. Thus, these data show that HIV transgenic mice are immunocompromised based on expression of envelope and regulatory proteins, in the absence of viral replication.
| Original language | English |
|---|---|
| Pages (from-to) | 321a |
| Journal | Journal of Investigative Medicine |
| Volume | 44 |
| Issue number | 3 |
| State | Published - 1996 |
Fingerprint
Dive into the research topics of 'HIV transgenic mouse model for disseminated cryptococcosis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver